Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,464Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4McCarthy Tétrault

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Apixaban

Brand Name : ELIQUIS

Patent Number : 2461202

Filing Date : 2002-09-17

Strength per Unit : 2.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-09-17

Date Granted : 2011-07-12

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Apixaban

Brand Name : ELIQUIS

Patent Number : 2349330

Filing Date : 1999-12-17

Strength per Unit : 2.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-12-17

Date Granted : 2009-09-29

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Apixaban

Brand Name : ELIQUIS

Patent Number : 2349330

Filing Date : 1999-12-17

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-12-17

Date Granted : 2009-09-29

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Apixaban

Brand Name : ELIQUIS

Patent Number : 2461202

Filing Date : 2002-09-17

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-09-17

Date Granted : 2011-07-12

blank